Skip to main content
Log in

NICE cost-effectiveness evaluations questioned in report

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Taylor D, et al. Licensed to Cure? Internet Document : 20 Mar 2014. Available from: URL: http://www.ucl.ac.uk

  2. Hawkins N. NICE uses wrong comparator to assess cost effectiveness of new drugs, report says. BMJ : 19 Mar 2014. Available from: URL: http://dx.doi.org/10.1136/bmj.g2134

    PubMed Central  PubMed  Google Scholar 

Download references

Additional information

* Licensed to Cure?

Rights and permissions

Reprints and permissions

About this article

Cite this article

NICE cost-effectiveness evaluations questioned in report. PharmacoEcon Outcomes News 699, 2 (2014). https://doi.org/10.1007/s40274-014-1124-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-014-1124-4

Navigation